Inhibition of the bile salt export pump (BSEP) can cause intracellular accumulation of bile acids and is a risk factor for drug-induced liver injury in humans. Antiretroviral protease inhibitors lopinavir (LPV) and ritonavir (RTV) are reported BSEP inhibitors. However, the consequences of LPV and RTV, alone and combined (LPV/r), on hepatocyte viability, bile acid transport, and endogenous bile acid disposition in rat hepatocytes have not been examined. 
Introduction
Antiretroviral protease inhibitors (PIs) continue to be a mainstay in the treatment of human immunodeficiency (HIV) infection. Despite their success, PIs have been associated with drug-induced liver injury (DILI), which is one of the most common adverse events leading to the discontinuation of PI-inclusive antiretroviral therapy (Sulkowski et al., 2000; Bongiovanni et al., 2005) . Liver injury occurred in 1% to 9.5% of PI-treated patients in randomized clinical trials conducted before US Food and Drug Administration approval (Sulkowski, 2004) . Retrospective and prospective cohort studies report an overall incidence rate between 5% and 23% for hepatotoxicity associated with PI-inclusive drug therapy. However, the PI dose and the definition of hepatotoxicity varied across the studies (Sulkowski, 2003) . In particular, ritonavir (RTV)-containing regimens reportedly increased the risk of hepatotoxicity by 8.6-fold (Sulkowski et al., 2000) . RTV is now administered at subtherapeutic (and subtoxic) doses to enhance systemic concentrations of coadministered PIs. One commonly prescribed PI combination is lopinavir (LPV) and ritonavir (LPV/r). Reportedly, patients on highly active antiretroviral therapy containing LPV/r who experienced liver failure exhibited higher LPV/r plasma concentrations compared with patients with normal functioning livers (package insert, Abbott Laboratories, Abbott Park, IL).
One proposed mechanism for DILI is that drugs or their metabolites impair the function of transport proteins responsible for the efflux of bile acids from the hepatocyte (McRae et al., 2006; Marion et al., 2007; Wolf et al., 2010) . Bile acids can cause cellular necrosis and apoptosis as a result of mitochondrial damage and disruption of cell membranes due to the detergent-like effects of these molecules (Pauli-Magnus et al., 2005) . Interference with the efflux of bile acids from hepatocytes could cause intracellular accumulation of bile acids, leading to toxicity.
The major transport protein responsible for biliary excretion of bile acids from the hepatocyte is the bile salt export pump (BSEP). Recent studies have shown that many drugs implicated in DILI inhibit BSEP (Morgan et al., 2010) . PIs, including LPV and RTV, also can inhibit bile acid transport via BSEP (McRae et al., 2006; Dawson et al., 2012) , supporting the idea that intracellular accumulation of bile acids may be a mechanism for DILI observed in patients treated with this combination (Morgan et al., 2010; Dawson et al., 2012) . If this is correct, we reasoned that the combination of LPV and RTV used in the clinic may have an additive or even synergistic effect on BSEP inhibition, resulting in an increased risk of DILI.
To our knowledge, the effect of PI combinations on hepatocyte viability and bile acid uptake or efflux has not been studied previously. Therefore, we examined the effects of LPV, alone and combined with RTV, on hepatocyte viability, bile acid transport, and endogenous bile acid disposition in rat hepatocytes. We hypothesized that each PI would cause hepatocellular accumulation of bile acids and toxicity and that coadministration of RTV and LPV would have at least an additive effect on bile acid accumulation and toxicity. QC, Canada) . The bile acids a-and b-tauromuricholic acid (a/b-TMCA) were purchased from Steraloids, Inc. (Newport, RI). TCA, lactate dehydrogenase (LDH), ATP, Triton X-100, Hanks' balanced salt solution (HBSS) premix, HBSS modified (with no calcium chloride, magnesium sulfate, phenol red, and sodium bicarbonate) premix, dexamethasone, and collagenase (type IV) were purchased from Sigma-Aldrich (St. Louis, MO). Dimethyl sulfoxide (DMSO) was obtained from Fisher Scientific (Fairlawn, NJ). GIBCO-brand fetal bovine serum, recombinant human insulin, and Dulbecco's modified Eagle's medium (DMEM) were purchased from Invitrogen (Carlsbad, CA). Insulin, transferrin, and selenium (ITS) Universal Culture Supplement Premix and Matrigel Basement Membrane Matrix were obtained from BD Biosciences (Palo Alto, CA). The CellTiter-Glo Luminescent Cell Viability Assay was purchased from Promega (Madison, WI). LDH Cytotoxicity Detection Kit was purchased from Roche Applied Sciences (Indianapolis, IN). All other chemicals and reagents were of analytical grade and were readily available from commercial sources.
Hepatocyte Isolation and Culture in a Sandwich Configuration. Hepatocytes were isolated from male Wistar rats (270-300 g) obtained from Charles River Laboratories, Inc. (Raleigh, NC) using a two-step collagenase perfusion method, previously described (LeCluyse et al., 1996) . Animals had free access to water and food before surgery and were allowed to acclimate for at least 5 days. All animal procedures complied with the guidelines of the Institutional Animal Care and Use Committee (University of North Carolina at Chapel Hill, Chapel Hill, NC).
Hepatocytes were seeded at 1.75 Â 10 6 cells per well on six-well, or 0.35 Â 10 6 cells per well on 24-well, BioCoat collagen plates in DMEM containing 5% fetal bovine serum, 10 mM insulin, 1 mM dexamethasone, 2 mM L-glutamine, 1% MEM nonessential amino acids, 100 units of penicillin G sodium, and 100 mg of streptomycin sulfate. Cells were incubated for 2 h at 37°C in a humidified incubator (95% O 2 , 5% CO 2 ) and allowed to attach to the collagen substratum, after which time the medium was aspirated to remove unattached cells and replaced with fresh medium. Approximately 24 h later, cells were overlaid with BD Matrigel at a concentration of 0.25 mg/ml in ice-cold feeding medium (DMEM with 1% ITS, 0.1 mM dexamethasone, 2 mM L-glutamine, 1% MEM nonessential amino acids, 100 units of penicillin G sodium, and 100 mg/ml of streptomycin sulfate). The culture medium was changed daily thereafter. Rat hepatocytes were cultured for at least 3 days to allow for the formation of bile canalicular networks.
Cytotoxicity and Cell Viability Assays. After 24-h exposure to PIs, intracellular ATP levels were measured using the CellTiter-Glo Luminescent Cell Viability Assay. All reagents were allowed to equilibrate to room temperature before use. The CellTiter-Glo Reagent was prepared by adding lyophilized CellTiter-Glo substrate to CellTiter-Glo buffer and mixing by vortex. Hepatocytes cultured in 24-well plates were allowed to equilibrate for at least 30 min to reach room temperature before the assay was performed. Medium was aspirated from each well twice and replaced with equal volumes of fresh feeding medium and CellTiter-Glo reagent. Plates were placed on an orbital shaker for 2 min to induce cell lysis and then incubated at room temperature for 10 min to allow the luminescent signal to stabilize.
Leakage of LDH into sandwich-cultured rat hepatocyte (SCRH) medium was determined using the LDH Cytotoxicity Detection Kit. Briefly, on day 3, SCRHs in 24-well plates were exposed to PIs for 24 h, after which cell-free supernatant was collected and aliquots were placed in individual wells of a 96-well plate. The substrate mixture was added to the culture supernatant and incubated for 30 min. During this time, LDH released from hepatocytes into the supernatant reduced the tetrazolium salt 2-(4-iodophenyl)-3-(4-nitrophenyl)-5-phenyl-2H-tetrazolium chloride (INT) to formazan by a coupled enzymatic reaction. After incubation, formazen formation was measured directly in the 96-well opaque-walled microplate by an enzyme-linked immunosorbent assay absorbance plate reader at 492 nm. To compare assays directly, LDH data were converted to viability and expressed as a percentage of control by subtracting the degree of toxicity (%) from 100%. Maximum cell death was represented by the values measured after complete cell lysis by 0.5% Triton X-100. Cells were then aspirated twice, and uptake was terminated by rinsing wells with 2 ml of ice-cold standard HBSS. After rinsing, cells were lysed with 0.1% Triton X-100 in phosphate-buffered saline and placed on an orbital shaker for 20 min. Aliquots of sample (500 ml) and dosing solution (100 ml) were collected for quantification of radioactivity by liquid scintillation counting. Another 500-ml aliquot of sample was reserved for protein quantification using the Pierce BCA Protein Assay Kit (Thermo Scientific, Rockford, IL C]CDCA; 25 nCi/ml) in suspended rat hepatocytes was measured in the presence of vehicle (DMSO), LPV (10 mM), or RTV (5 mM), alone and combined, using methods previously described . Uptake studies were performed in Na + -containing buffer to measure total uptake (Na + -dependent and Na + -independent) and Na + -free, cholinecontaining buffer (Na + -independent uptake only). Na + -dependent uptake was calculated by subtracting the Na + -independent uptake from the total uptake. Briefly, cells were washed twice in ice-cold buffer containing sodium chloride or choline chloride (137 mM NaCl or choline chloride, 0.8 mM MgSO 4 , 10 mM HEPES, 1.2 mM CaSO 4 , 0.86 mM K 2 HPO 4 , 0.14 mM KH 2 PO 4 , and 5 mM glucose, pH 7.4). Cells were resuspended at 1.0 Â 10 6 cells/ml in the same buffer, kept on ice, and used immediately in experiments. Hepatocyte suspensions (4 ml; n = 3 livers, in triplicate) were preincubated in bottom-inverted Erlenmeyer flasks at 37°C for 5 min; 0.1% DMSO or PIs were added 30 s before the addition of [ Baur and colleagues (1975) . Uptake was normalized to protein concentrations for individual hepatocyte suspensions as determined by the BCA protein assay reagent kit. Cellular viability of the suspended hepatocytes (.90%) was determined by trypan blue exclusion at the beginning and end of each experiment. Accumulation of Endogenous Bile Acids in Cells + Bile, Cells, and Culture Medium of Sandwich-Cultured Rat Hepatocytes. After 24-h exposure to vehicle or PIs, 1-ml aliquots of medium were collected from day 4 SCRH in six-well format and stored at 280°C until analysis. The remaining culture medium was aspirated from all wells, and triplicate wells were rinsed with 1.5 ml/well of warmed HBSS containing calcium (cells + bile) or HBSS without calcium (cells alone). After rinses, the wells were aspirated twice, and another 1.5 ml of HBSS, with or without calcium, was added to the wells, and cells were incubated at 37°C for 4 min. After incubation, the HBSS buffer was aspirated from all wells. Plates were sealed and stored at 280°C until analysis.
Liquid Chromatography Coupled with Tandem Mass Spectrometry Analysis. Culture medium and cell lysate samples were prepared for liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) analysis as described previously (Marion et al., 2011) . Briefly, six endogenous conjugated bile acid species [TCA, glycocholic acid (GCA), taurochenodeoxycholic acid (TCDCA), glycochenodeoxycholic acid (GCDCA), and a/b-TMCA] were detected simultaneously; 10 ml of sample or calibration standards were injected onto a Shimadzu binary high-performance liquid chromatography system (Columbia, MD). Chromatographic conditions used were as follows: 60% 0.5 mM ammonium acetate:40% MeOH (solvent A) and 20% 0.5 mM ammonium acetate:80% MeOH (solvent B) at a flow rate of 50 ml/min. The initial mobile phase was 70% solvent A:30% solvent B. The gradient was increased rapidly to 100% of solvent B for 2 to 15 min and then returned to initial conditions (solvent A) for 1 min. The autosampler was maintained at 4°C and rinsed with 1500 ml of 50:50 (v/v) 50% methanol:50% water after aspiration. Methanol (100%) was added at 10 ml per minute as a postcolumn solvent. Tandem MS used to quantify analytes was performed using a Thermo Electron TSQ Quantum Discovery MAX (Thermo Fisher Scientific, Inc., Charlotte, NC) with an Ion Max ESI (Thermo Fischer Scientific, Inc.) source in negative ion electrospray ionization mode using selected reaction monitoring. The concentration ranges of the standard curves for rat cell lysate and medium of each bile acid were 0.5-100 pmol per well and 0.5-50 pmol/100 ml of medium, respectively. For a detailed list of the transitions monitored at unit resolution, see Marion et al. (2011) .
When rat lysate and medium samples were analyzed initially, LC-MS/MS raw data were collected on a-and b-TMCA, but they were not processed. Both a-and b-TMCA have the same MS precursor and product negative ions as TCA; thus, their MS data were collected in the same analytical run as TCA. Once standards for a-and b-TMCA became available, they were used to confirm the identity of the LC-MS/MS response in the TCA channel thought to be a/b-TMCA. Because of the chromatographic separation used here, TCA was well resolved from a-and b-TMCA; however, a-and b-TMCA, which are stereoisomers, were measured collectively (designated a/b-TMCA). Using recently generated standard curves for b-TMCA from rat lysate (10-2000 pmol/well) and medium (1.0-500 pmol/100 ml), the original raw data collected for a/b-TMCA, along with the data for the other bile acids, were processed. The new a/b-TMCA standard curves were not generated with a stable isotope equivalent but were corrected for endogenous a/b-TMCA background. Similarly, the raw data for the glycine conjugates of a-and b-muricholic acid were collected but not processed in the original analytical run. Unfortunately, standards for these glycine conjugates currently are not commercially available.
Data Analysis. Cells + bile and cellular concentrations of bile acids were calculated based on estimates of hepatocyte intracellular volume (6.83 ml/well) and the number of cells per well . Medium concentrations were calculated based on a volume of 1.5 ml per well. For bile acid accumulation studies, the in vitro biliary excretion index (BEI; %), defined as the percentage of accumulated substrate residing within the bile canaliculi, was calculated using B-CLEAR technology (Qualyst Transporter Solutions, Durham, NC) according to the following equation:
BEI ¼ Accumulation standard buffer 2 Accumulation Calcium-free buffer Â 100% Accumulation standard buffer (Liu et al., 1999b) . The in vitro biliary clearance (Cl bile ) was calculated based on the following equation:
Cl bile ¼ Accumulation standard buffer 2 Accumulation Calcium-free buffer AUC medium where AUC medium represents the product of the incubation time (10 min) and the initial concentration in the incubation medium. Statistical analyses (oneway analysis of variance and Bonferroni's multiple comparison post-test) were performed using GraphPadPrism 3.0 (GraphPad Software, Inc., San Diego, CA). In all cases, P , 0.05 was considered statistically significant.
Results
Assessment of Cellular Viability in Sandwich-Cultured Rat Hepatocytes. Prior studies have shown that it takes 3 days for rat hepatocytes to regain polarity in sandwich culture (Dunn et al., 1991; Liu et al., 1998; Liu et al., 1999a) . Because polarity is necessary to assess the vectorial transport of bile acids, we examined the effects of 24-h RTV and LPV treatment, alone and combined, on cellular viability and bile acid disposition between culture day 3 and day 4. LDH release and cellular ATP content were measured after individual and combination treatment with LPV and RTV. Alone, LPV and RTV demonstrated concentration-dependent effects on cellular viability; the observed differences between the two treatments were not significant (Fig. 1) . Toxicity was not detected, or was minimal, at concentrations ,50 mM for each PI. Since toxicity may affect metabolic and transport processes involved in bile acid disposition in the SCRH model, PI concentrations #50 mM were used in subsequent studies. Cellular viability after exposure to the combination of LPV (5-50 mM) and RTV (5 mM) was comparable to LPV alone (Table 1) , and the trend toward increased toxicity at 50 mM of LPV was not statistically significant. Fig. 1 . Effect of 24-h exposure to lopinavir or ritonavir on hepatocyte viability in sandwichcultured rat hepatocytes. Day 3 SCRH were treated with LPV (squares; 5-100 mM) or RTV (triangles; 5-100 mM) for 24 h. After incubation, lactate dehydrogenase release (A) and cellular ATP levels (B) were measured. Data are presented as mean 6 SEM (n = 3). (Fig. 2) . However, when RTV was combined with LPV, the hepatocyte concentration of [ 3 H]TCA (7.7 6 0.1 pmol/mg protein) was significantly increased relative to the cellular concentrations observed with either vehicle or 5 mM LPV alone (5.1 6 0.7 and 5.0 6 0.5 pmol/mg protein, respectively). When the same experiment was repeated with [
14 C]CDCA, the treatments did not significantly alter the accumulation of [
14 C]CDCA species in cells + bile or cells alone (Fig. 3) . (Iga and Klaassen, 1982; Marion et al., 2007) . Initial uptake rates of [ 3 H]TCA in Na + -containing and Na + -free buffer were 1.53 6 0.11 and 0.15 6 0.07 pmol/s per milligram of protein, respectively (n = 3; Fig. 4 ). LPV (10 mM), RTV (5 mM), and LPV/r had no effect on the initial uptake rates of [ 3 H]TCA in Na + -containing or Na + -free buffer compared with vehicle control. Similarly, LPV, RTV, and LPV/r had no effect on the initial uptake rates of [ 14 C]CDCA in Na + -containing and Na + -free buffer of vehicle control hepatocytes (9.92 6 3.02 and 6.73 6 2.19 pmol/s per milligram of protein, respectively; n = 3; Fig. 5) .
Accumulation of Endogenous Bile Acids in Cells + Bile, Cells, and Medium of Sandwich-Cultured Rat Hepatocytes. TCA, GCA, TCDCA, GCDCA, and a/b-TMCA were measured in cells + bile, cells, and medium of SCRH. Taurine-conjugated bile acids accounted for most (approximately 99%) of the bile acid species detected in and cells (white bars), in day 4 SCRH were determined after a 10-min coincubation with RTV (5 mM) and LPV (5 mM), alone or combined (LPV/r) (mean 6 SEM; n = 3 livers in triplicate; analysis of variance followed by a Bonferroni post test, *, versus cells + bile vehicle control; #, versus 5 mM LPV alone; P , 0.05). vehicle-treated SCRH, consistent with data from in vitro rat studies published previously (Barth et al., 2006) . Concentrations (micromoles per liter) of each bile acid species in cells + bile, cells, and medium of vehicle-treated SCRH are listed in Table 3 . The a-and b-TMCA species constituted most of the total measured bile acid pool and appeared predominantly in the cells of SCRH. The BEI value of endogenous TCA (49%) was in the same range as the BEI calculated after the addition of 1 mM [ 3 H]TCA (68%; Table 2). It is not possible to calculate the biliary clearance of endogenously synthesized bile acids based on the current study design.
Accumulation of total endogenous bile acids (sum of TCA, GCA, TCDCA, GCDCA, and a/b-TMCA) in medium, cells, and bile of SCRH also was determined after 24-h incubation with vehicle, LPV (5 or 50 mM), and RTV (5 mM), alone or combined. Surprisingly, all treatments, except 5 mM LPV, significantly decreased total bile acid accumulation compared with vehicle control. This marked reduction in total measured bile acids is consistent with the observation that 24-h LPV exposure yielded minimal apparent toxicity to SCRH at these concentrations ( Fig. 1; Table 1 ). The addition of 5 mM RTV to lowdose LPV (5 mM) significantly decreased total bile acid accumulation relative to both vehicle and 5 mM LPV alone (Fig. 6 ). The addition of 5 mM RTV to 50 mM LPV did not further decrease endogenous bile acid accumulation relative to 50 mM LPV alone (Figs. 6-9 ).
The addition of 5 mM RTV to low-dose LPV (5 mM) significantly decreased TCDCA accumulation in cells + bile and cells alone relative to both vehicle and 5 mM LPV alone (Fig. 8) . In contrast, TCA and a/b-TMCA accumulation in cells + bile and cells alone was not significantly influenced by LPV (5 mM), either alone or combined with RTV (Figs. 7 and 9, respectively). LPV (50 mM) significantly reduced TCA accumulation in medium and cells + bile (Fig. 7) , TCDCA accumulation in cells + bile and cells alone (Fig. 8) , and a/b-TMCA accumulation in cells + bile (Fig. 9) , relative to vehicle. Interestingly, TCDCA accumulation in cells + bile and cells alone was significantly decreased by 5 mM RTV (Fig. 8) . Notably, the BEI of TCDCA was markedly decreased by RTV, alone or in combination with LPV (values at the top of Fig. 8) .
The GCA accumulation in cells + bile was significantly decreased from control by 5 mM LPV combined with 5 mM RTV (1.53 6 0.42 versus 0.14 6 0.14 pmol per milligram of protein) and nearly abolished by exposure to high-dose LPV, in the absence and presence of RTV. GCDCA was essentially undetectable in cells + bile and cells of SCRH treated with 5 mM LPV combined with RTV or with high-dose LPV (50 mM), alone or combined with 5 mM RTV. Medium GCA and GCDCA were not statistically different after PI exposure relative to vehicle control values. + -containing or Na + -free buffer, respectively. Uptake into cells is reported as picomoles per milligram of protein (pmol/mg) (mean 6 SEM; n = 3 livers in triplicate).
TABLE 3
Bile acid concentrations (mM) in cells + bile, cells, and medium, and biliary excretion index values for each bile acid species in day 4 sandwich-cultured rat hepatocytes Data represent mean 6 SEM (n = 3 livers in triplicate). Calculations assume a hepatocyte volume of 6.83 ml/well. The biliary excretion index was calculated as described in the methods. dmd.aspetjournals.org
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Discussion
Inhibition of BSEP-mediated biliary excretion of bile acids is a proposed mechanism of DILI. LPV and RTV inhibit BSEP in vitro and are associated with hepatotoxicity. HIV treatment regimens frequently combine RTV with other PIs to improve oral bioavailability, but they are associated with increased liver toxicity. The present work characterizes the interactions between hepatocytes, PIs, and bile acids. We hypothesized that the addition of RTV to LPV would result in increased toxicity and intracellular accumulation of bile acids in SCRH.
SCRH regain in vivo-like morphologic properties, including the development of tight junctions, polarized transport, and functional canalicular networks; metabolic capacity (e.g., bile acid synthesis and secretion) and functional regulatory machinery are well documented in SCRH (Swift et al., 2010) . Periodic contractions of the networks, as described for isolated hepatocyte couplets or hepatocyte groups (Oshio and Phillips, 1981; Phillips et al., 1982) , return canalicular contents to the medium (LeCluyse et al., 1994) . Mathematical modeling of SCRH data consistently requires a rate constant for substrate flux from the canalicular compartment (Liu et al., 1999b; Hoffmaster et al., 2005; . Thus, when cultured under appropriate conditions, SCRH do not exhibit biliary stasis, intracellular bile acids are within the range of previously reported values (Marion et al., 2012) , and SCRH exhibit toxicity when BSEP is inhibited (Kemp and Brouwer, 2004; Marion et al., 2007; Ogimura et al., 2011) . The content of reduced glutathione in SCRH is normal and is decreased markedly by exposure to toxicants that deplete glutathione in vivo (Kiang et al., 2011) . Therefore, we selected the SCRH model for the present studies. Indisputably, species differences exist between rodents and humans regarding drug-mediated toxicity and drug-transporter interactions. For example, potent inhibition of the bile salt analog cholylglycylamido-fluorescein by RTV in rat, but not in human, hepatocytes has been reported (Ye et al., 2010) . However, rodents remain the major preclinical in vivo screen to assess the potential hepatotoxicity of new drug candidates.
Contrary to our hypothesis, LPV/r did not significantly increase toxicity relative to LPV alone (Table 1) . Nonetheless, short-term (10-min) exposure of SCRH to LPV/r further increased TCA cellular accumulation compared with LPV alone (Fig. 2) . It is important to note that our transport inhibition studies were conducted after 10 min of PI exposure, whereas toxicity was assessed after 24 h of PI exposure. The lack of toxicity observed at 24 h may indicate that normal-functioning hepatocytes respond to cellular injury via hepatoprotective mechanisms. Alternatively, feedback mechanisms may downregulate bile acid synthesis or upregulate bile acid efflux, causing only transient increases in intracellular bile acids.
As expected from previous reports (McRae et al., 2006) C]CDCA species were not associated with similar increases in hepatocyte content of bile acids, we speculated that the PIs differentially inhibited basolateral uptake of bile acids. Modulating the Na + content of the buffer provides an accurate estimate of the contribution of the Na + -dependent transporter, Ntcp, and the sodium-independent organic anion transporting polypeptides (Oatps) to total uptake. Basolateral uptake of TCA is governed primarily by Ntcp and to a lesser extent by Oatps (Pauli-Magnus et al., 2005) . Conversely, CDCA uptake is driven predominantly by Oatps, whereas Ntcp contributes to a lesser degree (Marion et al., 2011) . Consistent with previous work, about 90% of the initial uptake rate of TCA into hepatocytes preincubated with vehicle (0.1% DMSO) was Ntcp-mediated; about 10% was driven by sodiumindependent transporter-mediated processes (presumably Oatps). Conversely, about 69% of transporter-mediated [ 14 C]CDCA uptake occurred in Na + -free buffer, consistent with published reports that Oatp transporters are primarily responsible for initial CDCA uptake (Kemp et al., 2005; Marion et al., 2011 This article reports, for the first time, the effects of PIs on the disposition of bile acids synthesized by SCRH. Although the bile acid pool comprises numerous bile acid species, this study focused on quantification of taurine-and glycine-conjugated cholic acid and chenodeoxycholic acid because of their potential cytotoxicity (Danielsson, 1973b; Danielsson, 1973a; Ellis et al., 1998) . Additionally, the aforementioned bile acids are common to both human and rodent bile. The rodent-specific a/b-TMCA species represent most of the rat bile acid pool. Secondary bile acids (produced via intestinal metabolism) are not synthesized in the SCRH system and thus were not quantified (Thomas et al., 2008) . BEI values for endogenous TCA were comparable to those estimated after the addition of [ (Figs. 7 and 9 ). The addition of RTV to 50 mM LPV had little additive effect. However, the addition of RTV to low-dose LPV (5 mM) significantly reduced the accumulation of endogenously synthesized total bile acids and TCDCA in SCRH relative to LPV alone (Figs. 6 and 8) . The extent of the combined effect of LPV and RTV on Bsep inhibition differs considerably between 10-min and 24-h exposure. In addition, RTV-mediated inhibition of CYP3A4 metabolism may increase cellular LPV or RTV concentrations, which may alter bile acid synthesis. The precise mechanism(s) responsible for PI-mediated decreases in endogenous bile acids are the subject of ongoing studies. These data also suggest that LPV and RTV alter the synthesis and biliary excretion of individual bile acids differentially.
The remarkable decrease in total measured bile acid content may be due to reduced bile acid synthesis. Consistent with this conclusion, 24-h RTV (15-100 mM) exposure reportedly perturbed bile acid synthesis in a concentration-dependent manner by decreasing the activity of cholesterol 7a-hydroxylase, the rate-limiting enzyme in bile acid catabolism (Zhou et al., 2006) . Based on these findings, the observed decrease in total measured bile acids after PI exposure in SCRH probably involves regulatory feedback mechanisms that promptly reduce synthesis of bile acids as a protective mechanism. An important dmd.aspetjournals.org conclusion drawn from our studies is that quantification of hepatocellular concentrations of endogenous bile acids may be required when establishing a relationship between drug-mediated inhibition of hepatic transporters and hepatotoxicity.
An important question is how the effects of LPV and RTV on bile acid excretion from hepatocytes relate to the hepatotoxicity observed clinically. At steady state, LPV and RTV are 98% to 99% bound to plasma proteins (albumin and AAG). The average unbound fraction of LPV in plasma was 0.73% and ranged from 0.14% to 1.68% (Fayet et al., 2008) . Total and unbound LPV plasma concentrations in HIVinfected patients ranged from 677 to 23,767 ng/ml (;1-38 mM) and 4.2 to 209.2 ng/ml (0.007-0.33 mM), respectively. PI concentrations selected for these studies exceeded reported unbound plasma concentrations because the clinically relevant unbound intracellular PI concentrations are unknown, but may exceed systemic concentrations as a result of transporter-mediated accumulation in hepatocytes and inhibition of intracellular metabolism and excretion.
In summary, 10-min LPV and RTV exposure reduced biliary excretion and, consequently, intracellular accumulation of TCA in SCRH. However, after 24-h exposure to LPV and RTV, we were unable to demonstrate even additive toxicity. We observed a marked reduction in hepatocyte accumulation of endogenous bile acids (sum total of TCA, GCA, TCDCA, GCDCA, and a/b-TMCA), primarily attributed to decreased a/b-TMCA. These observations do not necessarily refute a role for bile acid transport inhibition in DILI observed in patients treated with PIs. This is because most patients treated with PIs do not develop hepatotoxicity. We speculate that initial PI-mediated increases in cellular bile acid concentrations initiate a cascade of events that enables hepatocytes to remain healthy in most patients. This adaptive response includes mechanisms that decrease hepatocyte content of bile acids, most likely involving reduced synthesis. Such responses may not occur in all patients treated with these drugs. If such deficiencies have a genetic basis, their identification could lead to a personalized medicine approach to avoid DILI in PI-containing regimens.
